Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same
US8586550B2 · kind B2 · utility
25Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2011 |
| Grant date | Nov 19, 2013 |
| Priority date | — |
| Expiry date | Jun 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a novel compound with thiazole ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.